Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques is a research paper published in PLoS Pathogens (2021). On theSindex it has a DataRank of 0.470. It has been cited 22 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.470
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH Office of the Director
Grant: P51OD011107
National Institute of Allergy and Infectious Diseases
Grant: 1R21AI143454-02S1
National Institute of Allergy and Infectious Diseases
Grant: 3RF1AG061001
NIAID NIH HHS
Grant: T32 AI060555
NIA NIH HHS
Grant: RF1 AG061001
NIAID NIH HHS
Grant: R21 AI143454
MeSH Terms